XML 13 R2.htm IDEA: XBRL DOCUMENT v3.19.1
Condensed Consolidated Balance Sheets (Current Period Unaudited) - USD ($)
Mar. 31, 2019
Dec. 31, 2018
ASSETS    
Cash and cash equivalents $ 175,985 $ 259,701
Grant funds and other receivables 160,277 121,814
Prepaid expenses and other current assets 111,647 238,189
Total current assets 447,909 619,704
Property and equipment, net (Note 5) 13,725 11,350
Deposits 11,010 11,010
Total assets 472,644 642,064
LIABILITIES AND STOCKHOLDERS’ EQUITY (DEFICIENCY)    
Accounts payable 253,166 125,859
Accrued expenses (Note 6) 1,378,710 1,238,552
Current portion of notes payable (Note 7) 12,500 260,420
Total current liabilities 1,644,376 1,624,831
Note payable, net of current portion (Note 7) 35,417 39,580
Total liabilities 1,679,793 1,664,411
Commitments (Note 8)
Stockholders’ equity (deficiency):    
Common stock, $.001 par value: authorized shares – 600,000,000 issued and outstanding shares – 556,489 and 437,807 at March 31, 2019 and December 31, 2018, respectively 556 438
Additional paid-in capital 37,898,525 37,482,766
Accumulated deficit (41,178,338) (40,476,884)
Total stockholders’ equity (deficiency) (1,207,149) (1,022,347)
Total liabilities and stockholders’ equity (deficiency) 472,644 642,064
Series B Convertible Preferred Stock [Member]    
Stockholders’ equity (deficiency):    
Convertible Preferred Stock 76,095 76,095
Series C Convertible Preferred Stock [Member]    
Stockholders’ equity (deficiency):    
Convertible Preferred Stock 705,238
Series E Convertible Preferred Stock [Member]    
Stockholders’ equity (deficiency):    
Convertible Preferred Stock 1,190,000
Conversion of Series F Preferred Stock Into Common Stock [Member]    
Stockholders’ equity (deficiency):    
Convertible Preferred Stock 1,591,763
Series G Convertible Preferred Stock and Related Warrants [Member]    
Stockholders’ equity (deficiency):    
Convertible Preferred Stock $ 404,250